The new "liquid biopsy" test searches for tiny fragments of DNA that are shed by tumours into the bloodstream.

Bernstein 41st Annual Strategic Decisions Conference Call May 29, 2025 10:00 AM ETCompany ParticipantsStephane Bancel - ...

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

AbilityScore® — is helping families, therapists, and governments track child progress like never before. Read how this ...

A pharmaceutical-grade cannabidiol (CBD) product was shown to be safe in high-risk patients hospitalized with COVID-19, with ...

Management of Tinnitus in Patients with and without Hearing Loss: A Systematic Review. International Journal of ...

India’s heart ached over the movie Baghban. But countless stories of abuse behind closed doors and rapidly filling ashrams ...

The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma ...

A new drug to treat the early stages of Alzheimer’s disease has been approved for use in Australia from today.

The exponential interest in neurology blood-based biomarkers stems from the technical breakthroughs in testing brought about ...

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...